Page last updated: 2024-10-26

dilazep and Focal Segmental Glomerulosclerosis

dilazep has been researched along with Focal Segmental Glomerulosclerosis in 2 studies

Dilazep: Coronary vasodilator with some antiarrhythmic activity.
dilazep : A member of the class of diazepanes that is 1,4-diazepane substituted by 3-[(3,4,5-trimethoxybenzoyl)oxy]propyl groups at positions 1 and 4. It is a potent adenosine uptake inhibitor that exhibits antiplatelet, antianginal and vasodilator properties.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Numabe, A1
Ara, N1
Hakamada-Taguchi, R1
Suzuki, N1
Hirawa, N1
Kawabata, Y1
Negoro, T1
Nagata, T1
Goto, A1
Toyo-Oka, T1
Fujita, T1
Uehara, Y1
Nakazawa, K1
Moriya, T1
Kasai, S1
Yamazaki, T1
Komiyama, Y1
Shigematsu, H1
Akiba, T1
Koga, T1

Other Studies

2 other studies available for dilazep and Focal Segmental Glomerulosclerosis

ArticleYear
Effects of the anti-platelet aggregation drug dilazep on cognitive function in Dahl salt-sensitive rats.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2003, Volume: 26, Issue:2

    Topics: Animals; Avoidance Learning; Behavior, Animal; Blood Pressure; Cognition; Diet, Sodium-Restricted; D

2003
Dilazep prevents glomerulosclerosis in accelerated Masugi nephritis in the rat.
    Nihon Jinzo Gakkai shi, 1993, Volume: 35, Issue:4

    Topics: Animals; Dilazep; Disease Models, Animal; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; K

1993